Tuesday, June 1, 2021

Martin and Harris Laboratories Pre IPO Review & Analysis | Planify

MARTIN AND HARRIS LABORATORIES | LATEST SHARE PRICE & UPDATES  

Company Overview

Martin & Harris Laboratories Ltd incorporated in 1996 at Gurgaon, Haryana is a part of “Apeejay Group”, India’s oldest and largest business conglomerates. Martin & Harris Laboratories Ltd is engaged in the manufacturing of pharmaceutical, medicinal chemical & botanical products. Besides the core business, it was undertaken the management of its funds through investment in different avenues fetching good returns i.e mutual funds, equity – quoted & unquoted, etc.

The company has its units located at Roorkee and UNA Himachal Pradesh. It is constantly taking steps to modernize and expand its manufacturing units to meet international standards.

Martin & Harris Laboratories Limited is a manufacturing arm of  – One of India’s most well-renowned pharma companies. Walter Bushnell is also a part of the Apeejay Stya & Svran Group of companies.


It provides – bactericidal antibiotics, Parkinson's disease, vaginal infections, antispasmodic drugs, fertilization medicines, progestin medication, vitamin medicines, anabolic steroids, hormonal medicines, ovulatory stimulants, etc.

SUBSIDIARY COMPANY: “Delite Infrastructure Pvt Ltd”

Delite Infra is a wholly-owned subsidiary of Martin & Harris Laboratories Ltd. It is engaged in the business of Derivatives (F&O) trading, office rental income, investment income, and gain in the sale of shares.

Key Highlights of Martin & Harris

  • Book Value is increasing at a CAGR of 36% from the last 6 years.
  • Debt Free Company
  • PE multiple of 4 makes it the best choice to invest
  • Share Price of Martin & Harris is trading below the book value makes it attractive
  • 2 new plants ensure future growth of the company

The company has its units located at Roorkee and UNA Himachal Pradesh. It is constantly taking steps to modernize and expand its manufacturing units to meet international standards.

The Company has been awarded “Best Innovative in process & formulation development” by the director-general of health service, ministry of the health & family welfare, Government of India. Has also received “Pharma Excellence Awards 2018” by apex industry chamber ASSOCHAM.

For More Information watch this video :


No comments:

Post a Comment